abstract |
The invention belongs to the field of biomedicine, in particular to a methylation marker combination for diagnosing pancreaticobiliary tract cancer. Specifically, the methylation markers include one or more of SOX17, 3-OST-2, NXPH1, SEPT9 and TERT. |